BR9915761B1 - sistema de distribuiÇço de droga protÉica usando mimÉticos de membrana. - Google Patents

sistema de distribuiÇço de droga protÉica usando mimÉticos de membrana.

Info

Publication number: BR9915761B1
Authority: BR; Brazil
Prior art keywords: delivery system; drug delivery; protein drug; membrane mimetics; mimetics
Prior art date: 1998-09-27

Application number

BRPI9915761-6A

Other languages

English (en)

Other versions

BR9915761A (pt

Inventor

Pankaj Modi

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-09-27

Filing date

1999-09-27

Publication date

2010-12-14

1999-09-27 Application filed filed Critical

2001-07-24 Publication of BR9915761A publication Critical patent/BR9915761A/pt

2010-12-14 Publication of BR9915761B1 publication Critical patent/BR9915761B1/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Dispersion Chemistry (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Obesity (AREA)
Hematology (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

BRPI9915761-6A 1998-09-27 1999-09-27 sistema de distribuiÇço de droga protÉica usando mimÉticos de membrana. BR9915761B1 (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US09/161,447 US6193997B1 (en)	1998-09-27	1998-09-27	Proteinic drug delivery system using membrane mimetics

Publications (2)

Publication Number	Publication Date
BR9915761A BR9915761A (pt)	2001-07-24
BR9915761B1 true BR9915761B1 (pt)	2010-12-14

Family

ID=22581206

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI9915761-6A BR9915761B1 (pt)	1998-09-27	1999-09-27	sistema de distribuiÇço de droga protÉica usando mimÉticos de membrana.

Country Status (14)

Country	Link
US (1)	US6193997B1 (pt)
EP (1)	EP1115381B1 (pt)
JP (1)	JP2002525309A (pt)
AR (1)	AR023055A1 (pt)
AT (1)	ATE357215T1 (pt)
AU (1)	AU749892B2 (pt)
BR (1)	BR9915761B1 (pt)
CA (1)	CA2345075A1 (pt)
DE (1)	DE69935602T2 (pt)
DK (1)	DK1115381T3 (pt)
ES (1)	ES2285860T3 (pt)
MX (1)	MXPA01003156A (pt)
NZ (1)	NZ510191A (pt)
WO (1)	WO2000018371A1 (pt)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2686899B1 (fr) *	1992-01-31	1995-09-01	Rhone Poulenc Rorer Sa	Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
US6290987B1 (en) *	1998-09-27	2001-09-18	Generex Pharmaceuticals, Inc.	Mixed liposome pharmaceutical formulation with amphiphiles and phospholipids
US6451286B1 (en) *	1998-12-21	2002-09-17	Generex Pharmaceuticals Incorporated	Pharmaceutical compositions for buccal and pulmonary administration comprising an alkali metal alkyl sulfate and at least three micelle-forming compounds
US6375975B1 (en) *	1998-12-21	2002-04-23	Generex Pharmaceuticals Incorporated	Pharmaceutical compositions for buccal and pulmonary application
US7087215B2 (en) *	1998-12-21	2006-08-08	Generex Pharmaceuticals Incorporated	Methods of administering and enhancing absorption of pharmaceutical agents
AU2006200276B2 (en) *	1998-12-21	2007-11-29	Generex Pharmaceuticals Inc.	Micellar pharmaceutical compositions for buccal and pulmonary application
US6849263B2 (en) *	1998-12-21	2005-02-01	Generex Pharmaceutical Incorporated	Pharmaceutical compositions for buccal delivery of pain relief medications
US6350432B1 (en) *	1999-03-19	2002-02-26	Generex Pharmaceuticals Incorporated	Pressurized container having an aerosolized pharmaceutical composition
GB0007150D0 (en) *	2000-03-24	2000-05-17	Lamellar Therapeutics Limited	Immunotherapeutic methods and compositions
US6432383B1 (en) *	2000-03-30	2002-08-13	Generex Pharmaceuticals Incorporated	Method for administering insulin
AU2001266557A1 (en) *	2000-04-12	2001-10-23	Human Genome Sciences, Inc.	Albumin fusion proteins
DK1326630T3 (da)	2000-09-18	2008-09-15	Sanos Bioscience As	Anvendelse af GLP-2-peptider
US7371721B2 (en)	2000-09-18	2008-05-13	Sanos Bioscience A/S	Use of GLP-2 and related compounds for the treatment, prevention, diagnosis, and prognosis of bone-related disorders and calcium homeostasis related syndromes
SG126676A1 (en) *	2001-05-09	2007-01-30	Nanomaterials Tech Pte Ltd	Process for the controlled production of organic particles
AU2002302316A1 (en) *	2001-05-10	2002-11-18	Kuhs Gmbh And Co. Kg	Topical lamellar double membrane structure composition containing n-acyl-ethanolamine and/or a quaternary ammonium salt and/or adenosylmethionine
AU2002310122A1 (en) *	2001-05-25	2002-12-09	Human Genome Sciences, Inc.	Chemokine beta-1 fusion proteins
CN1335182A (zh) *	2001-08-08	2002-02-13	华中科技大学	胰岛素口腔喷剂及其制备工艺
DE10148065A1 (de) *	2001-09-28	2003-04-17	Max Planck Gesellschaft	(Ester)-Lysolecithine in Liposomen
WO2003047493A2 (en) *	2001-12-03	2003-06-12	Dor Biopharma Inc.	Stabilized reverse micelle compositions and uses thereof
AU2002364587A1 (en) *	2001-12-21	2003-07-30	Human Genome Sciences, Inc.	Albumin fusion proteins
JP5424521B2 (ja) *	2001-12-21	2014-02-26	ヒューマンジノームサイエンシーズ，インコーポレイテッド	アルブミン融合タンパク質
GB0207653D0 (en)	2002-04-03	2002-05-15	Lamellar Therapeutics Ltd	Methods of using lamellar bodies for therapeutic purposes
DE10214983A1 (de) *	2002-04-04	2004-04-08	TransMIT Gesellschaft für Technologietransfer mbH	Vernebelbare Liposomen und ihre Verwendung zur pulmonalen Applikation von Wirkstoffen
US8435942B2 (en) *	2002-05-31	2013-05-07	Transdermal Biotechnology, Inc.	Methods for formulating stabilized insulin compositions
US20040018237A1 (en) *	2002-05-31	2004-01-29	Perricone Nicholas V.	Topical drug delivery using phosphatidylcholine
CA2489528A1 (en) *	2002-06-20	2003-12-31	Novartis Consumer Health S.A.	Nasal compositions comprising a mucopolysaccharide and propylene glycol
CA2513213C (en)	2003-01-22	2013-07-30	Human Genome Sciences, Inc.	Albumin fusion proteins
GB0322448D0 (en)	2003-09-25	2003-10-29	Lamellar Therapeutics Ltd	Using lamellar bodies to modify linear biological macro molecules
WO2005053643A1 (ja) *	2003-12-01	2005-06-16	Mitsubishi Pharma Corporation	リポソーム
CN1557479A (zh) *	2004-01-16	2004-12-29	深圳市海王英特龙生物技术股份有限公	干扰素脂质体乳膏
WO2005072701A1 (en) *	2004-01-20	2005-08-11	Allergan, Inc.	Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid
US20050238632A1 (en) *	2004-04-23	2005-10-27	Alburty David S	Propellant formulations
CA2876767C (en) *	2005-10-03	2018-07-10	Mark A. Pinsky	Liposomes comprising hyaluronic acid and their use in improved skin care
WO2010027479A2 (en)	2008-09-08	2010-03-11	Children's Medical Center Corporation	Mucosal delivery of therapeutic molecules, proteins, or particles coupled to ceramide lipids
DE102009031274A1 (de)	2009-06-30	2011-01-13	Justus-Liebig-Universität Giessen	Liposomen zur pulmonalen Applikation
AU2010323117B2 (en)	2009-11-25	2015-09-03	Capsugel Belgium Nv	Mucosal delivery compositions comprising a peptide complexed with a crown comppound and/or a counter ion
CA2830298C (en)	2011-03-17	2016-08-16	Transdermal Biotechnology, Inc.	Topical nitric oxide systems comprising lecithin and methods of use thereof
EP3385294B1 (de)	2011-12-20	2020-11-11	Adhesys Medical GmbH	Isocyanatfunktionelles präpolymer für einen biologisch abbaubaren gewebeklebstoff
US8871256B2 (en)	2012-09-19	2014-10-28	Transdermal Biotechnology, Inc.	Methods and systems for treatment of inflammatory diseases with nitric oxide
US8871261B2 (en)	2012-09-19	2014-10-28	Transdermal Biotechnology, Inc.	Cancer treatments and compositions for use thereof
US8871258B2 (en)	2012-09-19	2014-10-28	Transdermal Biotechnology, Inc.	Treatment and prevention of learning and memory disorders
US8871255B2 (en)	2012-09-19	2014-10-28	Transdermal Biotechnology, Inc.	Treatment of skin and soft tissue infection with nitric oxide
US8871262B2 (en)	2012-09-19	2014-10-28	Transdermal Biotechnology, Inc.	Compositions and methods for treatment of osteoporosis and other indications
US8871259B2 (en)	2012-09-19	2014-10-28	Transdermal Biotechnology, Inc.	Techniques and systems for treatment of neuropathic pain and other indications
US8871257B2 (en)	2012-09-19	2014-10-28	Transdermal Biotechnology, Inc.	Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
US8871260B2 (en)	2012-09-19	2014-10-28	Transdermal Biotechnology, Inc.	Methods and compositions for muscular and neuromuscular diseases
US8871254B2 (en)	2012-09-19	2014-10-28	Transdermal Biotechnology, Inc.	Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
US9849160B2 (en)	2013-03-13	2017-12-26	Transdermal Biotechnology, Inc.	Methods and systems for treating or preventing cancer
US9687520B2 (en)	2013-03-13	2017-06-27	Transdermal Biotechnology, Inc.	Memory or learning improvement using peptide and other compositions
US9314422B2 (en)	2013-03-13	2016-04-19	Transdermal Biotechnology, Inc.	Peptide systems and methods for metabolic conditions
US9295647B2 (en)	2013-03-13	2016-03-29	Transdermal Biotechnology, Inc.	Systems and methods for delivery of peptides
US9320758B2 (en)	2013-03-13	2016-04-26	Transdermal Biotechnology, Inc.	Brain and neural treatments comprising peptides and other compositions
US20140271937A1 (en)	2013-03-13	2014-09-18	Transdermal Biotechnology, Inc.	Brain and neural treatments comprising peptides and other compositions
US9314433B2 (en)	2013-03-13	2016-04-19	Transdermal Biotechnology, Inc.	Methods and systems for treating or preventing cancer
US20140271938A1 (en)	2013-03-13	2014-09-18	Transdermal Biotechnology, Inc.	Systems and methods for delivery of peptides
US9241899B2 (en)	2013-03-13	2016-01-26	Transdermal Biotechnology, Inc.	Topical systems and methods for treating sexual dysfunction
US9393265B2 (en)	2013-03-13	2016-07-19	Transdermal Biotechnology, Inc.	Wound healing using topical systems and methods
US9320706B2 (en)	2013-03-13	2016-04-26	Transdermal Biotechnology, Inc.	Immune modulation using peptides and other compositions
US9750787B2 (en)	2013-03-13	2017-09-05	Transdermal Biotechnology, Inc.	Memory or learning improvement using peptide and other compositions
US9295637B2 (en)	2013-03-13	2016-03-29	Transdermal Biotechnology, Inc.	Compositions and methods for affecting mood states
US9339457B2 (en)	2013-03-13	2016-05-17	Transdermal Biotechnology, Inc.	Cardiovascular disease treatment and prevention
US9393264B2 (en)	2013-03-13	2016-07-19	Transdermal Biotechnology, Inc.	Immune modulation using peptides and other compositions
US9314423B2 (en)	2013-03-13	2016-04-19	Transdermal Biotechnology, Inc.	Hair treatment systems and methods using peptides and other compositions
US9387159B2 (en)	2013-03-13	2016-07-12	Transdermal Biotechnology, Inc.	Treatment of skin, including aging skin, to improve appearance
US9295636B2 (en)	2013-03-13	2016-03-29	Transdermal Biotechnology, Inc.	Wound healing using topical systems and methods
US9724419B2 (en)	2013-03-13	2017-08-08	Transdermal Biotechnology, Inc.	Peptide systems and methods for metabolic conditions
US9314417B2 (en)	2013-03-13	2016-04-19	Transdermal Biotechnology, Inc.	Treatment of skin, including aging skin, to improve appearance
US20140271731A1 (en)	2013-03-13	2014-09-18	Transdermal Biotechnology, Inc.	Cardiovascular disease treatment and prevention
US20160151283A1 (en) *	2014-11-27	2016-06-02	Icnoderm S.R.L.	Hyalurosomes, their use in topical cosmetic or pharmaceutical compositions and their preparation process
CA3080521A1 (en)	2017-10-27	2019-05-02	Children's Medical Center Corporation	Short chain ceramide-based lipids and uses thereof
CA3096398A1 (en)	2018-04-12	2019-10-17	Children's Medical Center Corporation	Ceramide-like lipid-based delivery vehicles and uses thereof
US11198831B2 (en)	2019-01-31	2021-12-14	Kvi Llc	Lubricant for a device

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2408387A2 (fr)	1975-06-30	1979-06-08	Oreal	Compositions a base de dispersions aqueuses de spherules lipidiques
FR2571963B1 (fr)	1984-10-24	1987-07-10	Oreal	Composition a usage cosmetique ou pharmaceutique contenant des niosomes et au moins un polyamide hydrosoluble et procede de preparation de cette composition.
US5234767A (en)	1987-03-13	1993-08-10	Micro-Pak, Inc.	Hybrid paucilamellar lipid vesicles
US5147723A (en)	1987-07-28	1992-09-15	Micro-Pak, Inc.	Paucilamellar lipid vesicles
US4895452A (en) *	1988-03-03	1990-01-23	Micro-Pak, Inc.	Method and apparatus for producing lipid vesicles
JP3765579B2 (ja) *	1990-08-24	2006-04-12	イーデーエーアーアーゲー	作用物質投与用超微小滴状調剤
US5260065A (en)	1991-09-17	1993-11-09	Micro Vesicular Systems, Inc.	Blended lipid vesicles
US5643600A (en)	1991-09-17	1997-07-01	Micro-Pak, Inc.	Lipid vesicles containing avocado oil unsaponifiables
US5653987A (en) *	1995-05-16	1997-08-05	Modi; Pankaj	Liquid formulations for proteinic pharmaceuticals
DE69732308T2 (de) *	1996-09-27	2005-06-02	Jagotec Ag	Arzneistoffverabreichungssystem mit hyaluronsäure
US6017545A (en) *	1998-02-10	2000-01-25	Modi; Pankaj	Mixed micellar delivery system and method of preparation

1998
- 1998-09-27 US US09/161,447 patent/US6193997B1/en not_active Expired - Lifetime
1999
- 1999-09-23 DE DE69935602T patent/DE69935602T2/de not_active Expired - Lifetime
- 1999-09-23 AU AU58435/99A patent/AU749892B2/en not_active Ceased
- 1999-09-23 JP JP2000571892A patent/JP2002525309A/ja not_active Withdrawn
- 1999-09-23 ES ES99945793T patent/ES2285860T3/es not_active Expired - Lifetime
- 1999-09-23 AT AT99945793T patent/ATE357215T1/de not_active IP Right Cessation
- 1999-09-23 DK DK99945793T patent/DK1115381T3/da active
- 1999-09-23 NZ NZ510191A patent/NZ510191A/xx not_active IP Right Cessation
- 1999-09-23 MX MXPA01003156A patent/MXPA01003156A/es not_active IP Right Cessation
- 1999-09-23 CA CA002345075A patent/CA2345075A1/en not_active Abandoned
- 1999-09-23 EP EP99945793A patent/EP1115381B1/en not_active Expired - Lifetime
- 1999-09-23 WO PCT/CA1999/000879 patent/WO2000018371A1/en not_active Ceased
- 1999-09-24 AR ARP990104815A patent/AR023055A1/es active IP Right Grant
- 1999-09-27 BR BRPI9915761-6A patent/BR9915761B1/pt not_active IP Right Cessation

Also Published As

Publication number	Publication date
DE69935602T2 (de)	2007-12-06
AU5843599A (en)	2000-04-17
EP1115381A1 (en)	2001-07-18
BR9915761A (pt)	2001-07-24
ATE357215T1 (de)	2007-04-15
AR023055A1 (es)	2002-09-04
AU749892B2 (en)	2002-07-04
NZ510191A (en)	2002-09-27
JP2002525309A (ja)	2002-08-13
CA2345075A1 (en)	2000-04-06
ES2285860T3 (es)	2007-11-16
DE69935602D1 (de)	2007-05-03
DK1115381T3 (da)	2007-07-23
WO2000018371A1 (en)	2000-04-06
MXPA01003156A (es)	2003-05-15
EP1115381B1 (en)	2007-03-21
US6193997B1 (en)	2001-02-27

Publication	Publication Date	Title
BR9915761B1 (pt)	2010-12-14	sistema de distribuiÇço de droga protÉica usando mimÉticos de membrana.
BR9801027B1 (pt)	2009-01-13	sistema de distribuiÇço de medicamentos.
BR0015252B1 (pt)	2009-01-13	sistema de dispensa.
BR0013705B1 (pt)	2009-01-13	sistema cirérgico.
PT1051217E (pt)	2003-12-31	Sistema de controlo osmotico de administracao de medicamento
BR0015191B1 (pt)	2010-11-16	sistema de suporte de pressão.
ATE291417T1 (de)	2005-04-15	Gastrointestinales wirkstoffverabreichungssystem
EE200000546A (et)	2002-02-15	Aerosoolistatud toimeaine manustamissüsteem
BR9900981B1 (pt)	2013-12-03	Sistema de transcodificação
DE69705994D1 (de)	2001-09-13	Fahrbahnsensor und Navigationssystem, das diesen Sensor verwendet
IT1319846B1 (it)	2003-11-03	Sistema di attacco modulare.
ZA200103297B (en)	2001-10-25	Membrane or matrix for controlling drug permeation.
DE69932415D1 (de)	2006-08-31	Im aufzug gebrauchtes meldungs-lieferungssystem
BR0015759B1 (pt)	2009-01-13	sistema de estrutura de fârma modular dotada de curvatura variÁvel.
NO20024194L (no)	2002-09-03	Nytt selvemulgerende legemiddelavleveringssystem
BR0005420B1 (pt)	2008-11-18	sistema de conector, e, conector.
DE60037258D1 (de)	2008-01-10	System zur verwaltung des endpunktschlages
BR0007617B1 (pt)	2008-11-18	sistema de deslizamento.
BR0013303B1 (pt)	2008-11-18	melhoramento em sistema de acionamento.
BR0104086B1 (pt)	2009-05-05	sistema de injeção.
IT1306775B1 (it)	2001-10-02	Sistema di interruttori.
MXPA01003810A (es)	2003-10-14	Sistema de administracion para somatotropina porcina. ..
IT1308689B1 (it)	2002-01-09	Sistema di aterectomia rotazionale con palloncino laterale.
IT1293743B1 (it)	1999-03-10	Sistema di decodificazione secam
IT1305289B1 (it)	2001-05-04	Sistema e procedimento per la erogazione di carburante utilizzando larilevazione e la visualizzazione del numero di ottano.

Legal Events

Date	Code	Title	Description
2009-02-17	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2009-02-17	B15K	Others concerning applications: alteration of classification	Free format text: ALTERADA DA INT.CL: A61K 9/127, A61K 38/16, A61K 47/06 Ipc: A61K 9/127 (2009.01), A61K 38/16 (2009.01), A61K 3
2010-03-30	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2010-12-14	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 14/12/2010, OBSERVADAS AS CONDICOES LEGAIS.
2014-04-08	B21F	Lapse acc. art. 78, item iv - on non-payment of the annual fees in time	Free format text: REFERENTE A 14A ANUIDADE.
2015-11-24	B24J	Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)	Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2257 DE 08-04-2014 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.